Windsor Creek Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Windsor Creek Advisors's AMGN Position: Q4 2021 in Review
Windsor Creek Advisors increased its Amgen (AMGN) stake by 14% in Q4 2021, buying an estimated $579K and bringing the position to 21,659 shares worth $4.39M. The position accounts for 1.33% of the portfolio, ranked #20.
Windsor Creek Advisors first reported a position in AMGN in Q1 2019 and has held it in 12 quarters since. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.
- Windsor Creek Advisors held 21,659 shares of Amgen worth $4.39M as of Q4 2021.
- Windsor Creek Advisors bought 2,741 Amgen shares in Q4 2021, an estimated $579K.
- Amgen made up 1.33% of Windsor Creek Advisors's portfolio in Q4 2021, its #20 holding.
- Windsor Creek Advisors first reported a position in Amgen in Q1 2019 and has held it in 12 quarters since.
- 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.
Based on Windsor Creek Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.